(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 6.39% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.63%.
Qiagen Nv's revenue in 2025 is $1,966,174,000.On average, 7 Wall Street analysts forecast QGEN's revenue for 2025 to be $465,235,343,936, with the lowest QGEN revenue forecast at $462,766,130,624, and the highest QGEN revenue forecast at $467,833,973,760. On average, 5 Wall Street analysts forecast QGEN's revenue for 2026 to be $496,724,306,880, with the lowest QGEN revenue forecast at $489,909,564,736, and the highest QGEN revenue forecast at $500,033,608,000.
In 2027, QGEN is forecast to generate $532,189,580,960 in revenue, with the lowest revenue forecast at $532,189,580,960 and the highest revenue forecast at $532,189,580,960.